Attachment 111 - Page 3 
3 
We want to reemphasize the distinction between research and technology. 
We consider it appropriate that RAC continue to function as it new does in 
of its review of laboratory research without the addition of any new levels 
of review. We suggest that the Biotechnology Science Board be called the 
Biotechnology Board and not have oversight of basic laboratory research. 
terms 
4. What mechanisms will there be for general public discussion of issues of 
safety and benefit at each level of review? 
[ 410 ] 
